HCL Technologies Ltd said it signed a deal with Australia-based independent clinical research organisation, Novotech for implementing Oracle's Siebel Clinical Trial Management System (CTMS) over the next few months. No financial details were provided.
The Siebel CTMS will support Novotech's complete spectrum of CTMS across Asia Pacific. Siebel CTMS will serve as a centralised repository to collect and track information about clinical trials. The system will allow management of clinical trials at different tiers-local, regional and global.
CTMS will also offer an aggregate view of clinical trails undertaken by Novotech and provide up to date information to Novotech's clients on project progress. It will also provide timely and accurate reports and dashboards to support tactical and strategic decision making, the company said.
HCL Technologies will work with Novotech in phases, starting by assessing the company's current proprietary CTMS. HCL will then implement and validate the Siebel CTMS and provide training to enable Novotech in using the Siebel CTMS successfully.
On Monday, HCL shares declined 1.8% to Rs406 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.7% down at 20,852 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
